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Highlights 
 
 Experimental design allowed to optimize a formulation of guar orodispersible films 
 Alginate beads formulation was also optimized by experimental design 
 Formulations were not cytotoxic to TR146 human buccal cells 
 Combination of films and beads offers an effective buccal caffeine permeability 
 Developed formulation offers a controlled release of carried molecules 
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Abstract 
 
 
The association of alginate beads and guar-gum films in a single delivery system was 
idealized to promote a more effective buccal and oral delivery of bioactive molecules. A 
response surface method (experimental design approach) was performed to obtain 
optimal formulations of alginate beads to be incorporated into guar gum oral films as 
combined buccal and oral delivery systems for caffeine delivery. The combined 
formulation was further characterized regarding physicochemical properties, drug 
release, cell viability and buccal permeability. Beads average size, determined by 
dynamic light scattering (DLS), was of 3.37 ± 6.36 m. Film thickness was set to 62 m. 
Scanning electron microscopy micrographs revealed that beads were evenly distributed 
onto the film matrix and beads size was in accordance to data obtained from DLS analysis. 
Evaluation of Fourier-transform infrared spectra did not indicate the formation of new 
covalent bonds between the matrix of guar-gum films, alginate beads and caffeine. In 
vitro release assays by dialysis membrane allowed understanding that the combination of 
guar-gum films and alginate beads assure a slower release of caffeine when compared 
with the delivery profile of free caffeine from alginate beads or guar-gum films alone. 
MTT assay, performed on human buccal carcinoma TR146 cell line, allowed concluding 
that neither guar-gum film, alginate beads nor guar-gum film incorporated into alginate 
beads significantly compromised cell viability after 12 h of exposure. As demonstrated 
by in vitro permeability assay using TR146 human buccal carcinoma cell lines, 
combination of guar-gum films and alginate beads also promoted a slower release and, 
thus, lower apparent permeability (1.15E-05 ± 3.50E-06) than for caffeine solution 
(2.68E-05 ± 7.30E-06), guar-gum film (3.12E-05 ± 4.70E-06) or alginate beads (2.01E-
05 ± 3.90E-06). The conjugation of alginate beads within an orodispersible film matrix 
represents an effective oral/buccal delivery system that induces a controlled release along 
with an enhanced intimate contact with cell layers that may promote higher in vivo 
bioavailability of carried drugs. 
 
Keywords: 
Alginate Beads; Caffeine; Drug delivery; Experimental design; Oral films; Slow release. 
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 1. Introduction 
 
Buccal route is an attractive delivery route especially due to ease of administration 
and possibility to avoid first-pass metabolism [1]. Transport of drugs across buccal 
mucosa occurs exclusively by passive diffusion, an undifferentiated, unselective, 
transport mechanism [2]. Lipophilic bioactive molecules may permeate buccal mucosa 
by transcellular route whereas hydrophilic bioactive molecules are more prone to 
permeate buccal epithelia by intercellular route.  Moreover, buccal epithelium presents a 
molecular weight cut-off that ranges from 500-1000 Da [3]. Hence, molecules with 
superior molecular weights may be hindered from transposing buccal epithelia and reach 
systemic circulation. Furthermore, saliva turnover limits the residence time of drugs 
within buccal mucosa, sometimes leading to premature swallowing [1].  
Aiming to develop more effective buccal delivery systems, alginate beads 
containing caffeine as model drug were introduced within an orodispersible film matrix. 
Oral films are mucoadhesive oral delivery systems that disintegrate in the mouth in less 
than 30 s [3]. Besides from the inherent advantages shared with tablets or capsules (e.g. 
ease of administration and portability) administration of oral films does not require water. 
Moreover, oral films are especially useful for uncooperative patients since, once 
introduced into the mouth, and are very difficult to remove. Also, variables such as colour 
and taste are easily manipulated according to the preferences of the consumer/patient. 
Oral films are convenient delivery systems when buccal release is aimed [4].  
Alginate is a natural anionic copolymer of 1,4-linked--D-mannuronic acid and -
L-guluronic acid that is highly biocompatible and can be used to produce beads for buccal 
delivery of bioactive molecules [5]. Alginate beads can represent suitable delivery 
systems for the buccal mucosa, featuring mucoadhesion and sustained delivery of carried 
molecules. Production of alginate beads is cheap and does not imply using organic 
solvents, therefore being predictably safe for human consumption. For the entrapment of 
hydrophilic molecules, emulsification-internal gelation technique to produce alginate 
beads was used to provide high association efficiency for caffeine.   
Alginate beads/microparticles have been used as delivery systems for buccal 
delivery of drugs but, to our knowledge, were not intended for buccal absorption, only 
aiming local activity [6-8]. Furthermore, alginate has been used for the production of 
buccal delivery systems (e.g. tablets) but not in the format of beads [9]. Moreover, 
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incorporation of alginate beads on film matrices represents an unconventional, 
conceptually new oral/buccal delivery system that conjugates the practicality and user-
friendly characteristics of oral films and the slower release of carried bioactive molecules 
provided by alginate beads.  
An experimental design based on response-surface method allows obtaining 
optimized formulations, assuring quality-by-design, thus avoiding excessive expending 
of time and resources and allowing to obtain robust and optimal results. In this study, both 
alginate beads and guar-gum films formulations were optimized using an experimental 
design approach and optimal formulations were prepared, based on characteristics 
(factors and responses) that are well-known for conditioning overall quality and 
performance of beads and oral films. Therefore, chosen variables for the optimization of 
guar-gum films were the relative amounts of guar-gum (matrix-forming polymer), 
sorbitol (plasticizer and sweetener) and citric acid (saliva-stimulating agent). Distance at 
burst and film burst strength were chosen as mechanical responses, being directly 
correlated with elasticity and rigidity, respectively. Film erosion (%) and the ratio of 
water-uptake over time (mg.s-1) were set as representative responses of the capacity of 
the oral films to absorb water and disintegrate, releasing the content [10]. Film thickness 
was not controllable at the moment of the production of guar-gum films but is known as 
being an important factor for the variation of mechanical characteristics. Therefore, 
thickness was considered as a factor (independent variable) even though thickness values 
were not circumscribed to a pre-defined range at the moment of the experimental design 
[11]. Concerning the optimization of alginate beads, association efficiency (%), particle 
size (m), corresponding polydispersity index and -potential (mV) were set as responses 
for the variation of alginate and Tween® 80 concentrations.  
Authors attempted to gather the controlled release and mucoadhesion offered by 
alginate beads with the convenience and mucoadhesion of guar-gum oral films to obtain 
a buccal and oral delivery system that enhances buccal absorption and promotes an 
increased bioavailability of carried bioactive molecule, when compared with alginate 
beads or orodispersible films alone.  
 
2. Materials and Methods 
2.1. Materials 
Caffeine anhydrous (food chemicals codex, 99% purity), alginic acid (sodium salt 
from brown algae, molecular weight ranging from 80,000 to 120,000, 61% of mannuronic 
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acid and 39% of guluronic acid, as stated by supplier in safety and documentation 
section), guar-gum and D-sorbitol (assay purity ≥ 98%) were purchased from Sigma-
Aldrich (Steinheim, Germany). Citric acid monohydrate, calcium carbonate, potassium 
phosphate monobasic anhydrous, sodium phosphate dibasic were purchased from Merck 
(Darmstadt, Germany). Sodium chloride was purchased from Panreac (Barcelona, Spain). 
Methanol (HPLC gradient grade) was purchased from Fisher (Loughborough, United 
Kingdom). Deionized water was used to prepare all oral films formulations and ultrapure 
water was used to prepare caffeine standard solutions and eluents used in chromatography 
procedures. TR146 cell line (passage 9) was purchased from Sigma-Aldrich (Stenheim, 
Germany). Transwell® flasks (12 well) and inserts (collagen-coated, 1.12 cm2 of culture 
area, 0.4 m pore size and 12 mm membrane diameter) were purchased from Corning 
(New York, USA). 96-well plates were purchased from Thermo Scientific (Denmark). 
Fetal Bovine Serum (FBS), HAMS-F12 culture medium and Pen-Strep (10 000 U 
Penicillin, 10 000 U Streptomycin) were purchased from Lonza® (Verviers, Belgium). 
TrypLETM express was purchased from Gibco® (Denmark). Thiazolyl Blue Tetrazolium 
Bromide (MTT) Ultra Pure was purchased from VWR (Solon, USA). Dimethyl sulfoxide 
(DMSO) 99.7% was purchased from Fisher BioreagentsTM (EUA). For TR146 cell wash, 
pH of PBS was adjusted to 6.8, using a solution of hydrochloric acid 0.1 M. 
 
2.2. Experimental design 
Experimental design was performed recurring to SAS JMP® 9 software. Response 
surface method for the optimization of film formulation was defined using the amounts 
of guar-gum (polymer), sorbitol (plasticizer and sweetener) and citric acid (saliva 
production inducer) as factors (independent variables). Erosion, water-uptake/time ratio, 
distance at burst and film burst strength were set as responses (dependent variables).  
Alginate beads formulation was optimized by setting the relative amounts of 
sodium alginate and Tween® 80 as factors and association efficiency, -potential, mean 
size and polydispersity index were set as responses.  
2.2.1. Production and characterization of oral films 
Preparation of oral films was performed using solvent casting technique [11]. 
Briefly, guar gum, citric acid and sorbitol were dissolved into 100 mL of ultra-pure water. 
Thereafter, resulting solution was spread onto a glass cast heated to 50 ºC for 1 h. 
Resulting film was then maintained at room temperature for 12 h. Finally, individual films 
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(2 cm x 3 cm) were cut from the glass cast for further testing. Oral films were collected 
directly from the glass cast and packaged into thermo-sealed polyethylene sheets.  
 
2.2.1.1. Texture analysis 
Texture analysis was performed on a texturometer equipment (TA.XT plus Texture 
Analyser, Stable Micro Systems, Cardiff, UK). Force calibration for a 5 kg load cell was 
performed using a 2 kg weight and height calibration was performed for the film support 
rig and corresponding probe. Film burst strength (g) and distance at burst (mm) were 
considered as measures of rigidity and elasticity, respectively. 
 
2.2.1.2. Thickness measurement 
Thickness of the oral films was measured using a calibrated vernier gauge caliper 
micrometer. Thickness was measured in five points of each oral film and the average 
value was determined [12]. 
 
2.2.1.3. Water-uptake, erosion and disintegration time 
Water-uptake (WU) was determined by placing Guar-gum films in contact with 1 
mL of artificial saliva. Weight changes were registered at 30, 60, 90, and 120 s and WU 
was calculated according to Eq. (1) [10]. Afterwards, hydrated samples were introduced 
in an oven at 60 ºC for 24 h and weight variation of oral films was recorded in order to 
determine erosion. Erosion (%) represents the amount of film that was lost during the 
contact with artificial saliva and was calculated according to Eq. (2).  
 
𝑊𝑎𝑡𝑒𝑟 − 𝑢𝑝𝑡𝑎𝑘𝑒 (%) =  
(𝑊𝑡− 𝑊1)
𝑊𝑡
 ×  100 
𝐸𝑟𝑜𝑠𝑖𝑜𝑛 (%) =
(𝑊1−𝑊3)
𝑊1
 ×  100 
 
where, W1 is initial weight of tested oral films, Wt is the weight of the oral films 
after contact with artificial saliva at determined periods of time and W3 is the weight of 
dry oral films, after erosion. 
Since, according to United States Food and Drug Administration (FDA), oral films, 
as oral delivery systems, must disintegrate within 30 s in the oral cavity, the water-
uptake/time ratio was determined as an indicator of disintegration speed [13]. Water-
uptake/time ratio was calculated according to Eq. (3). 
(1) 
(2) 
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 𝑊𝑎𝑡𝑒𝑟 − 𝑢𝑝𝑡𝑎𝑘𝑒/𝑡𝑖𝑚𝑒 =
𝑊𝑎𝑡𝑒𝑟 − 𝑢𝑝𝑡𝑎𝑘𝑒 
𝑡(max 𝑤𝑎𝑡𝑒𝑟 − 𝑢𝑝𝑡𝑎𝑘𝑒)
  
 
where, water-uptake (%) is an indicator of water taken up by the oral film (Eq. 1) 
and t(max water-uptake) is the time (s) at which water-uptake (%) value was maximum.  
 
2.2.2. Production and characterization of alginate beads 
2.2.2.1. Production of alginate beads 
Alginate beads were prepared by emulsification/internal gelation [14]. Briefly, 
calcium carbonate and caffeine were dissolved into an alginate solution. In a separate 
beaker, Tween® 80 was dispersed into 10 mL of liquid paraffin. Both dispersions were 
stirred for 30 min and then the alginate solution was added drop wise to the paraffin 
dispersion and the resulting emulsion was kept stirring (600 rpm) for 30 min. Then, 
glacial acetic acid was added drop wise to the emulsion to liberate calcium ions for 
gelation. Resulting emulsion was kept stirring (900 rpm) for 1 h followed by 
centrifugation (6,000 rpm, 15 ºC) and the pellet was recovered and washed with PBS. 
Washing procedure was performed three times for each formulation of beads. Regarding 
the association of alginate beads with guar-gum films, beads were added to the film 
formulation and homogenized before being poured on a glass cast. Following, resulting 
formulation was heated to 50 ºC for 1 h and then rested at room temperature for 12 h, as 
described for the production of guar-gum films in section 2.2.1.  
 
2.2.2.2. Characterization of alginate beads 
Caffeine association efficiency (AE), mean size, -potential, scanning electron 
microscopy (SEM) and delivery profile were the parameters used to characterize alginate 
beads.  
2.2.2.2.1. Particle size and -potential analysis determination 
All alginate bead formulations were diluted (1:100) with ultrapure water 
before particle size and -potential analysis. Particle size and polydispersity index 
were determined by dynamic light scattering (DLS). -potential was determined 
by phase analysis light scattering. All measurements were performed in triplicate 
in a Zetasizer Nano ZSP equipment (Malvern Instruments Ltd, Worcestershire, 
UK).  
(3) 
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 2.2.2.2.2. Caffeine association efficiency (AE) 
Caffeine association efficiency was determined by dosing (HPLC-UV) the 
free caffeine content of the supernatant of each bead formulation after being 
centrifuged (6,000 rpm, 30 min, 16 ºC). Caffeine concentration in the supernatant 
was determined by HPLC-UV on a Waters Alliance® instrument (Milford, MA, 
USA). Water and methanol mixture (60:40) was used as mobile phase, column 
temperature was defined as 35 ºC and isocratic flow was set to 1 mL/min [15]. 
Samples were run through a Kromasil® C18 column, 5 m (particle size) × 4.6 
mm (internal diameter) × 250 mm (length) (AkzoNobel, Bohus, Sweden). UV 
detector wavelength was set to 270 nm. The injection volume was set to 50 l. 
Finally, caffeine association efficiency was calculated according to the following 
Eq. (4): 
 
𝑊𝑡𝑐 − 𝑊𝑠𝑐
𝑊𝑡𝑐
 ×  100                 (4) 
 
where, Wtc stands for total weight of caffeine used in the alginate bead 
formulations and Wsc stands for caffeine collected from the supernatant after 
centrifugation. 
 
2.3. Surface tension analysis  
A pendant drop tensiometer (PAT-1, SINTERFACE Technologies, Berlin, 
Germany) was used to measure dynamic surface tension of developed formulations at the 
air/water interface. A drop of the delivery systems dissolved in artificial saliva solution 
is formed at the tip of a capillary (constant volume: 12 µl), which is into a cuvette with 
water saturated atmosphere to avoid droplet evaporation, covered by a compartment, 
which is maintained at constant temperature (20 ± 0.2 ºC) by circulating water from a 
thermostat. It was allowed to stand for 30 min to reach constant temperature and humidity 
in the compartment. Then, the silhouette of this drop is cast onto a CCD camera and 
digitized. The digital images of the drop are recorded over time and fit to the Young-
Laplace equation to accurately (± 0.1 mN/m) determine surface tension using drop profile 
analysis tensiometry. All experiments were performed at 20 ºC and at least two 
measurements have been done for each system. The computer controlled dosing system 
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allows to control a constant volume of the drop during the measurement and also to induce 
area deformations [16]. All the glass materials were properly cleaned using a mixture of 
ammonium persulfate and sulphuric acid and further rinsed with ultrapure water to 
eliminate all the possible surface active contaminants that could interfere in the 
measurements. 
 
2.4. Molecular Interactions analysis 
ATR-FTIR analysis was performed for guar-gum films and alginate beads (placebo 
and with caffeine) to assess eventual chemical interactions with caffeine. Analysis was 
conducted in a FTIR spectrometer, model ABB MB3000 (ABB, Switzerland), equipped 
with a deuterated triglycine sulphate detector and using a MIRacleTM single reflection 
horizontal attenuated total reflectance (ATR) accessory (PIKE Technologies, USA) with 
a diamond/Se crystal plate. Obtained spectra were baseline corrected using a 3-4 point 
adjustment. Area of obtained spectra was normalized to a 0-1 range. Spectra treatment 
was performed using the OriginPro® (version 9.0) software. Spectra of caffeinated guar-
gum films, alginate beads, association of guar-gum films with alginate beads (GfB) and 
physical mixture of GfB formulation were subtracted from spectra of placebo guar-gum 
films, alginate beads and GfB, respectively [17]. Resulting spectra were compared with 
the spectra of pure caffeine anhydrous powder.  
 
2.5. Morphological analysis 
Morphological analysis was performed on a JEOL-5600 Lv Scanning Electron 
Microscope (Tokyo, Japan) equipped with SPRITE HR Four Axis Stagecontroller (Deben 
Research). Samples were placed on metallic stubs with carbon tape and coated with 
gold/palladium using a Sputter Coater (Polaron, Bad Schwalbach, Germany). Images 
were obtained for guar-gum films, alginate beads and GfB. using a spot size of 18-20 and 
a potential of 15-22 kV. All analyses were performed at room temperature (20 ºC).  
 
2.6. Caffeine release profile  
In vitro release assays were performed in order to assess and compare release 
profiles of guar-gum films, alginate beads and GfB. Briefly, in vitro dialysis delivery 
assay was performed according to Wang, Liu, Sun, Wang, Wang and Zhu [18]. Briefly, 
the formulations (alginate beads, guar-gum films and GfB) and a caffeine control solution 
(2 mg/mL) were introduced into a 500 Da dialysis membrane. Dialysis membrane with a 
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pore size of 500 Da was chosen to mimic the pore size of buccal mucosa [3]. Immediately, 
the dialysis membrane was filled with the formulations and 35 mL of artificial saliva 
(pH= 6.8), clumped and dipped into 50 mL of phosphate buffered saline - PBS  - solution 
(release media) pre-heated to 37 ºC. The system was kept on continuous shaking (100 
rpm). Aliquots of 5 mL were withdrawn from release media at 15, 30, 60, 120, 180, 240, 
300, 360, 420, 480, 540, 600, 660 and 720 min. Withdrawn volume was immediately 
replaced with 5 mL of PBS and pre-heated to 37 ºC to preserve sink conditions.  
 
2.7. Human buccal epithelium cell line line 
Cell viability after contact with produced formulations and transepithelial 
permeability assay were performed using TR146 human buccal epithelium cell line. 
TR146 cell line was chosen due to great resemblance of normal human buccal mucosa 
namely regarding undifferentiated, non-keratinized stratified epithelium, morphological 
and functional characteristics as activity of carboxypeptidase, esterase and 
aminopeptidase [19]. Also, expression of K4, K10, K13, K16 and K19 keratins, 
membrane-associated receptors for involucrin and epidermal growth factors also reflect 
other common characteristics to normal human buccal epithelium cells [20, 21].  
TR146 cell line was purchased from Sigma-Aldrich (USA) and passage 9 was used. 
The culture medium consisted of HAMS F-12 medium enriched with 2 mM Glutamine 
(Lonza), 10% (V/V) fetal bovine serum (FBS) and 1% (V/V) of penicillin-streptomycin 
antibiotic blend. TR146 cells were seeded and maintained in 75 cm2 T-flasks (T-75) and 
incubated in a 5% CO2/95% air and 98% relative humidity atmosphere. The culture 
medium was replaced every two days. When 70-80% of cell confluence was reached, 
cells were detached from T-75 flasks using 2 mL of TrypLETM Express. Detached cells 
were then prepared and seeded either in other T-75 flasks, 96-well culture plates (Nunc®) 
or in Transwell® inserts 12-well culture plates purchased from Corning® (Germany). 
 
2.7.1. Cell mitochondrial activity assessment 
Cell-viability studies were carried out on proliferating cells, chosen when TR146 
cells were 70-80% confluent in T-75 flasks and properly detached as described above. 
After detachment, cells were re-suspended in medium and seeded in 96-well plates at 
density of 1 x 104 cells/mL, 200 L per well. The same cell concentration was adopted in 
the 12-well plates but using 500 L of cell suspension, after in vitro permeability assay, 
to assess the cell viability after being in contact with developed formulations. Cell-
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viability studies were performed after 24 h of culture, with previous supervision by light 
microscopy of the morphology and confluence of the cells in the plate wells. MTT assay 
allows to assess mitochondrial viability and, therefore, cell viability after 12 h contact 
with prepared drug delivery systems [22]. If TR146 cells were viable, succinic 
dehydrogenase was able to transform the tetrazolium salt into insoluble, purple-coloured, 
crystals of formazan [23]. Medium with 1% (V/V) Triton X-100 solution was added as 
lysis buffer and served as positive control. Negative control consisted of cells in contact 
with medium only. After treatment with produced drug delivery formulations, 100 L of 
the MTT reagent (0.5 mg/mL prepared in culture medium) was added to each well and 
the plates were incubated for 4 h at 37 ºC and in a 5% CO2 atmosphere. After incubation 
time has passed, reagent was carefully removed, allowing the insoluble formazan crystals 
to remain in the bottom of the wells. 100 L of DMSO per well was used to solubilize 
the formazan crystals in a dark room and, after 15 min of agitation on an orbital shaker, 
the absorbance at 570 nm and 630 nm was read on a FLUOstar OPTIMA microplate 
reader (United Kingdom), in triplicate. Absorbance values for all readings at 630 nm were 
subtracted from the absorbance values read at 570 nm. Cell viability (%, n=5 different, 
independent wells for the same experiment) was calculated according to Eq. (5): 
 
𝐶𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 (%) =  
𝐸𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙 𝑣𝑎𝑙𝑢𝑒−𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝑛𝑒𝑔𝑎𝑡𝑖𝑣𝑒 𝑐𝑜𝑛𝑡𝑟𝑜𝑙
 ×  100              (5) 
 
Concentration of the formulations tested for potential commitment of TR146 cell 
viability were chosen according to the average amount of saliva produced in the human 
mouth when in contact with food products [24].  
 
2.7.2. Drug transepithelial diffusion study 
Permeability assay also assessed in Corning® Transwell® inserts, using 12-well 
plates. TR146 buccal cells were seeded onto the inserts to mimic stratified epithelium of 
human buccal mucosa, as reported previously [20, 25]. Briefly, TR146 cell line was used 
due to the reported similarities between keratinization profile and metabolic activity with 
physiologic human buccal mucosa cells. TR146 cells were seeded on the inserts and the 
medium was changed every two days for 21 days. For medium replacement, medium was 
removed from the wells and 0.5 and 1.5 mL of fresh culture medium was added to the 
apical and basolateral sides, respectively. On the day of the study, culture medium was 
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totally removed. Medium in the basolateral side (receptor part) was replaced with 1.5 mL 
of PBS, pH 6.8. Medium in the apical side (donor part) was replaced with fresh medium 
and drug delivery formulations were introduced afterwards. Guar-gum films, alginate 
beads, GfB and free caffeine were tested for permeability (n= 5). Samples of 600 L were 
withdrawn from receptor part at 0, 15, 30, 60, 120, 180, 240, 300, 360, 420, 480, 540, 
600, 660 and 720 min.  Withdrawn volume was immediately replaced with fresh PBS, 
pre-heated to 37 ºC, to maintain sink conditions. The amount of permeated caffeine was 
quantified by HPLC-UV, as described in section 2.5. 
The amount of caffeine that permeated Transwell® inserts with the stratified 
epithelium formed by confluent TR146 cells (dQ) was determined over the time intervals 
(dt) and the flux (J) was determined by calculating the slope of the resulting plots, 
according to Eq. (6) [26]. 
Papp (cm.s-1) was calculated for free caffeine, guar-gum films, alginate beads and 
GfB, by normalizing the flux (J) over the concentration of caffeine in the donor 
compartment (C0) according to Eq. (7). 
J =
dQ
A × dt
                                                                      (6) 
 
Papp =
J
C0
                                                                      (7) 
where, dQ/dt stands for the amount of permeated caffeine over time, A for the tissue 
surface area and C0 for the initial concentration of caffeine. All tested formulations 
presented the same initial concentration of caffeine (2 mg/mL) at the beginning of the 
drug trans-epithelial study.  
Caffeine remaining entrapped by the TR146 cell monolayer was obtained by 
disruption of the monolayer with 1 mL of DMSO. Resulting solution was centrifuged 
(14,000 rpm, 15 min, 4 ºC) and caffeine concentration in the supernatant was determined 
by HPLC-UV.  
At the end of the drug trans-epithelial diffusion study, MTT mitochondrial viability 
assay was performed in order to verify the viability of TR146 cells [27]. Inserts incubated 
with culture medium only, during the caffeine trans-epithelial study (n= 5) were 
considered as positive control (i.e. total cell viability). Inserts incubated with Triton-X 
lysis solution (n= 3) were considered as negative control (i.e. reference for total cell 
death). MTT assay was performed as described in section 2.13.1. 
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 2.8. Statistical analysis 
Statistical analysis regarding dissolution profile data was performed using IBM® 
SPSS® Statistics version 22.  
Shapiro-Wilk (n< 50) test was used to verify if the values obtained for the responses 
in the experimental design were normally distributed. One sample T test was used to 
verify the existence of statistically significant differences between predictive models and 
experimental values. Experimental values were obtained from three samples selected 
from three new batches, for both alginate beads and guar-gum films. Mean values for 
each batch were compared with the values predicted in the model.  
 
3. Results and discussion 
An experimental design was performed to optimize two formulations as delivery 
systems that can be used alone or combined for an enhanced buccal delivery of bioactive 
molecules. A physico-chemical characterization (analysis of molecular interactions and 
morphological analysis), a release assay, TR146 cell viability test and permeability assay 
were performed for developed formulations. 
 
3.1. Optimization of the formulation of guar-gum oral films and validation of 
results 
Factorial design (response surface method) performed for optimization of the guar-
gum films is briefly described in Table 1. 
 
Prediction profiler (Figure S1, supplementary materials) obtained from the 
experimental design allowed elaborating an optimized guar-gum films formulation with 
desired values of erosion (%), distance at burst (mm), film burst (g) and water-uptake/time 
(%, w/w.s-1) ratio.  
Since very wide standard-deviation values were obtained for responses (dependent 
variables), three batches of the guar-gum films formula predicted by the statistical model 
as being optimal were prepared and erosion (%), distance at burst (mm), film burst 
strength (g) and water-uptake/time (mg/s) ratio were determined (n= 6) and compared 
with theoretically predicted values. Oral films were prepared according to the prediction 
profiler, by dissolving 2.7 g of sorbitol, 2.0 g of guar gum and 0.380 g of citric acid in 
100 mL of ultrapure water. Only oral films with 0.06 mm were selected for validation 
AC
CE
PT
ED
 M
AN
US
CR
IPT
purposes. Predicted and experimental values for the optimized formulation of guar-gum 
films are outlined in Table 2.  
 
 No statistical differences (p > 0.05) were observed between mean predicted values 
and mean experimental values (Figure S2, supplementary materials).  
Many other polymers have been previously reported as having film-forming 
properties at similar concentrations as observed for guar-gum films [11]. Indeed, chitosan 
and sodium carboxymethylcellulose oral films were previously optimised by our group 
but disintegration times were much higher and drug release was very distinct from 
developed guar-gum films [28]. Moreover, chitosan oral films are reported as being 
astringent and, therefore, potentially unpleasant, compromising patient/consumer 
compliance. On the other hand, guar-gum is commonly used in food products as thickener 
in a wide array of products and consumers already accept the flavour and used to find 
guar-gum referred on packaging labels [29].  
Also, in comparison to mucoadhesive oral films recently developed, guar-gum 
films presented superior mechanical characteristics either regarding film burst strength 
(average of 1754.96 g for guar-gum films against 546.57 g for sodium 
carboxymethylcellulose films) or distance at burst (average of 5.77 mm for guar-gum 
films against 0.74 mm for sodium carboxymethylcellulose films) [30]. Distance at burst 
was similar to vaginal films (blend of 72% of hydroxypropylmethylcellulose, 18% 
polyvinyl alcohol and 10% glycerine) containing nanoparticles developed by our group 
(average of 5.77 mm for guar-gum films against 5.34 mm for vaginal films) indicating 
good elasticity characteristics [31].  
Indeed, mechanical characteristics are very important either to assure stability 
during transport, accurate dosage of carried bioactive molecules or to avoid handling and 
administration issues [32]. 
Unfortunately, there is still a great lack of information regarding standardized 
technological characteristics (e.g. mechanical characterization, dissolution and 
disintegration assays, shelf-life assessment and appropriate storing and packaging 
conditions) making the optimization of oral films formulations a task requiring further 
studies [11, 33-35].  
 
3.2. Optimization of the formulation of alginate beads and validation of results 
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Alginate beads formulation was optimized with the purpose of obtaining high 
stability and enhancement of residence time of caffeine in contact with buccal mucosa. 
The summary of the factorial design (response surface method) performed for the 
optimization of the formulation of alginate beads is outlined in Table 3.  Relative amounts 
of sodium alginate (particle-forming polymer) and Tween® 80 (polysorbate, surfactant) 
were chosen as factors for the optimization of alginate beads. Association efficiency, 
mean particle size, polydispersity index and -potential were selected as responses, being 
considered of main importance for the characterization of beads. Caffeine anhydrous was 
the model drug carried by alginate beads, attending to achieve sustained release. 
 
Prediction profiler (Figure S3, supplementary materials) allowed elaborating an 
optimized alginate beads formulation to achieve desired values of association efficiency 
(AE, %), mean particle size, polydispersity index (PdI) and -potential (mV). 
As observed for guar-gum films, since very wide standard deviation values were 
obtained for responses (dependent variables), three batches of alginate beads were 
prepared and mean values of AE (%), size (m), PdI and -potential (mV) were 
determined and compared with the average values predicted by the statistical model. 
Alginate beads were prepared using 3.0% (%, w/v) of alginate and 2.4% (%, w/v) of 
Tween® 80. Predicted and experimental values for the optimized formulation of alginate 
beads films are outlined in Table  4. 
 
No statistical differences (p > 0.05) were observed between mean predicted values 
and mean experimental values, except for -potential. Indeed, experimental values for -
potential were significantly inferior, i.e. more negative, than values predicted in the 
statistical model.  
A graphical analysis of one sample T-tests performed for validation of the 
prediction profiler is provided in Figure S4, supplementary materials. 
There is still a gap in the literature concerning microparticles as buccal delivery 
systems, albeit it has been reported by some researchers [36]. Nevertheless, most 
researchers are using nanoparticles aiming to increase apparent permeability of carried 
drugs and not to achieve a slower release of carried molecules. For instance, it has been 
reported that poly(lactide-co-glycolide) (PLGA) nanoparticles carrying acyclovir were 
incorporated into mucoadhesive buccal films and succeeded on increasing ex vivo 
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permeability of the drug across rabbit buccal mucosa [37].  Nevertheless, most works 
concerning the development of microparticles for buccal delivery are aiming local 
administration and not permeation across buccal mucosa to reach systemic circulation 
[38, 39]. Alginate was previously used to produce mucoadhesive microparticles by ionic 
gelation aiming to an increased residence time of drugs in the buccal mucosa. Effectively, 
alginate microparticles guaranteed an increased residence time of flurbiprofen and 
delmopinol when compared to reference solutions, decreasing the administration 
frequency [40].  
3.3. Dynamic surface tension analysis 
Analysis of water/air interfacial tension is outlined in Figure 1. The lower water/air 
surface tension was associated with higher possibility of the formulation to adhere to other 
solutions or surfaces (e.g. digestive juices or enteric tissues) [41]. Indeed, surface tension 
is a way of measuring the work of adhesion. The smaller the work of internal adhesion 
within the drop, the greater the possibility of interaction with external environment. 
 
The interfacial behaviour of developed formulations along with individualized  
components of the beads (i.e. Sodium alginate and Tween 80) reflected significant 
differences that can be translated into distinct mucoadhesion profiles. Indeed, it was 
observed that caffeine did not present interfacial activity.  
Artificial saliva solution presented a small variation of superficial tension along 
time as well, even though slightly more pronounced when compared to caffeine.  
On the other hand, sodium alginate presented tensioactive activity with a variation 
of 24 mN/m during the 7,000 seg of the assay, indicating a potentially favourable 
interaction with gastrointestinal mucosa. Tween 80 (polysorbate) induced the most 
extensive reduction of  surface tension  with time [42]. Effectively, Tween 80 is well-
known to present very expressive tensioactive activity and a high drop stability was 
expected.  
GfB and caffeine-loaded alginate beads presented the higher stabilization (i.e.  the 
lower the surface tension, the higher the possibility of interacting with external media as 
the buccal mucosa or absorptive epithelia along the gastrointestinal tract) capacity of all 
formulations, indicating that the association of caffeine with alginate beads is expected to 
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offer a greater interaction with gastrointestinal tract mucosa when compared with caffeine 
or excipients alone.  
Moreover, the incorporation of caffeine-loaded alginate beads within the guar-gum 
film matrix led to the greatest decrease in the surface tension of the drop (tween 80 is not 
being considered due to intrinsic tensioactive activity) indicating that the guar-gum film-
alginate beads synergism may potentially offer a higher mucoadhesion along 
gastrointestinal tract when compared to the remaining formulations [41].  
 
3.4. Molecular interaction analysis 
Attenuated total reflectance-Fourier-transform infrared (ATR-FTIR) analysis was 
performed to perceive the onset of new bonds between caffeine and developed 
formulations during production steps. 
Resulting infrared spectra achieved from the subtraction of alginate beads, guar-
gum films, GfB and for the physical mixture of all excipients of GfB and caffeine from 
corresponding placebo formulations is outlined in Figure 2. Spectra of caffeine 
anhydrous powder was used for comparison with obtained subtracted spectra.  
 
Typical caffeine bands that appear at 1700-1600 cm-1 are representative of the C=O 
stretch of amide I [43]. C-N stretch coupled with N-H bending of the amide II present in 
the caffeine molecule are represented by the bands at 1600-1500 cm-1. The bands showed 
in the range of 1666-1550 cm-1 are addressed to the stretches of C=C, C=O and C=N 
bonds of caffeine molecules [44, 45]. Subtracted spectra for alginate beads, guar-gum 
films, GfB and physical mixture of all excipients of GfB represented in Figure 2, showed 
the same characteristic infrared bands as caffeine anhydrous infrared spectra. Thus, there 
is no indication of the formation of new chemical bonds between caffeine and the 
excipients of alginate beads or guar-gum oral films during formulations processes. Also, 
there are no significant differences between caffeine spectra and the subtracted spectra 
for the physical mixture, revealing that the excipients do not induce alterations in the 
chemical structure of caffeine. Spectral analysis indicates that the formation of new 
chemical bonds that may hinder caffeine release from developed delivery systems is not 
observed. Instead, caffeine release from guar-gum films, alginate beads or GfB may be 
affected mainly by physical shielding and/or electrostatic bonds [28].  
 
3.5. Morphology analysis 
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Scanning electron microscopy (SEM) was used to perform a visual recognition of 
the matrix structure of oral films and alginate beads, in order to obtain further information 
regarding caffeine delivery profile. 
Morphology analysis of alginate beads, guar-gum films and alginate beads 
dispersed on oral films was performed by SEM (Figure S5, Supplementary materials).  
Alginate beads were added to guar-gum films formulation before solvent casting 
for the blend to be as homogeneous as possible. The fact that alginate beads are 
hydrophilic could represent a stability problem since it would be very likely that alginate 
would be dissolved in the guar-gum films matrix during solvent casting procedure. 
However, it is noticeable that alginate beads are homogeneously spread on the film 
matrix, indicating good stability of alginate beads. Also, bead size and morphology 
observed in the microphotographs are coherent with the size predicted by the statistical 
model and corroborated by DLS analysis that indicated that mean particle size is around 
3.58 m. Both size and shape of alginate beads were homogeneous. Also, some particle 
agglomeration seems to occur. Nevertheless, homogeneous dispersion of alginate beads 
into/onto the guar-gum films matrix indicates that caffeine dosage in each film is very 
similar and, thus, caffeine release profile is likely to be similar when testing different 
batches. Therefore, the chances of a successful future scale-up are promising. 
 
3.6. In vitro caffeine release assay 
The release assay using dialysis membranes was performed to characterize the 
delivery profile of caffeine from alginate beads, guar-gum films and the combination of 
both delivery systems (GfB) aiming to test a conceptually new oral delivery system. Pore 
size of dialysis membrane (500 Da) was chosen according to the intercellular space 
between epithelial cells of buccal mucosa [3, 46]. 
For the assessment of release profile of caffeine from developed delivery systems, 
guar-gum films and alginate beads alone and in combination were tested. Figure 3 
represents delivery profile from guar-gum films, alginate beads and GfB compared with 
a control solution of free caffeine (2 mg/mL). 
 
The higher flux of caffeine from control solution crossed the dialysis membrane 
occurred in the first 15 min, indicating that caffeine flux easily occurred from the inside 
of the dialysis membrane to the outside, following Fick’s first law. Caffeine is a small 
(194.194 g.mol-1), highly hydrophilic (2.16E04 mg/L) molecule and a fast efflux from the 
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dialysis membrane was predictable [47, 48]. Release profile of caffeine content in control 
solution was almost linear in the first 60 min, approaching a zero-order release kinetics 
and reaching a plateau from 60 min till the end of the release study. Indeed, caffeine is 
expected to permeate buccal mucosa according to the simplified version of Fick’s first 
law (Eq. (5)) by paracellular path [49, 50].  
 
𝐽 = 𝑃(𝐶𝑑𝑜𝑛𝑜𝑟 − 𝐶𝑟𝑒𝑐𝑒𝑖𝑣𝑒𝑟) 
 
where, P is the permeability coefficient, Cdonor and Creceiver are the 
concentrations of caffeine inside the dialysis membrane and on the receiver compartment, 
respectively, and J is the flux from the dialysis membrane (donor compartment) to the 
receiver compartment [50]. Caffeine release from guar-gum films was significantly 
slower than the control caffeine solution but fast disintegration of the film led, yet, to a 
significantly fast caffeine release to the outside of the dialysis membrane. Effectively, the 
same noticeable burst release of bioactive molecules loaded in a thin film was observed 
in other studies, indicating a clear trend regarding delivery of bioactive molecules from 
thin films [51, 52]. The differences observed between guar-gum films release profile and 
control may be due to physical and/or electrostatic hindrance of caffeine release from 
guar-gum films matrix. Caffeine release from alginate beads across dialysis membrane 
was significantly slower when compared with guar-gum films or control. The fact that 
caffeine molecules are associated (either inside or at the surface) to the alginate beads 
may delay the release of caffeine, therefore preventing a sooner passage across dialysis 
membrane pores. Indeed, alginate beads, may have to disintegrate for the entrapped 
caffeine to be free and able to cross the membrane. The combination of guar-gum films 
and alginate beads to form one delivery system offers the highest impedance of caffeine 
release over time. Indeed, the conjugation of guar-gum film and alginate matrices implies 
that caffeine must be released from a double barrier before contacting with the absorptive 
epithelium. Both film and bead matrices must disintegrate and dissolve to allow the 
complete release of caffeine. Nevertheless, caffeine release in the first 60 min was very 
similar for GfB and alginate beads. The initial burst release may be due to some premature 
release of caffeine from alginate beads shortly after the production of the formulations, 
as verified in other studies [31, 51].  
3.7. Cell viability studies 
(5) 
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TR146 cells were used to evaluate potential toxicity caused by different 
concentrations of caffeine-loaded alginate beads, guar-gum films and GfB. Placebo 
formulations with the same mass as caffeine-loaded delivery systems were used as 
controls. Cell viability was assessed by MTT reduction assay. 
Results of cell viability in vitro assay for placebo and caffeine-loaded alginate 
beads, guar-gum films and alginate beads incorporated into guar-gum films are shown in 
Figure 4. 
 
None of the tested concentrations of caffeine alone or incorporated into alginate 
beads, guar-gum films or GfB did significantly compromise cellular viability of TR146 
cells, after 12 h of exposure. Total TR146 cell viability indicates that, when administered 
per os there was no evidence that suggests that some of the drug delivery systems (either 
alone or combined) are hazardous for the buccal epithelium.  
 
3.8. Permeability assay on TR146 monolayers 
TR146 human buccal carcinoma cells were used to determine buccal permeability 
of caffeine from developed formulations. 
The permeation profiles through TR146 cells grown on Transwell® inserts were 
distinct according to the formulation (Figure 5).  
 
Values of the apparent permeability (cm.s-1) for all the formulations are outlined in 
Table S1, Supplementary contents.  
Results obtained for caffeine control solution (2 mg/mL) are in accordance with 
previously reported caffeine buccal apparent permeability [53, 54]. Also, caffeine control 
solution presented a permeability profile that strongly correlates with diffusion from 
dialysis membrane (Figure 2). Indeed, caffeine permeation also occurred according to 
Fick’s first law following a zero-order kinetics. Caffeine released from guar-gum films 
permeated TR146 cell layer faster than the control caffeine solution for 100 min. After 
being inserted into the Transwell® inserts, guar-gum films began disintegrating. Then, 
fragments resulting from disintegration of guar-gum films deposited and adhered to the 
apical layer of TR146 cells. Immediate adhesion of guar-gum films fragments offered a 
higher contact surface area with the cell layer and thus, more effective caffeine 
permeation. Effectively, mucoadhesive delivery systems were reported, by peer 
researchers, to increase permeation of carried molecules across TR146 cell layer [55]. 
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Both alginate beads and GfB offered slower caffeine permeation when compared with 
guar-gum films or caffeine control solution. Lower permeation of caffeine across TR146 
cell layer may be at least partially due to the slower caffeine release, as observed in the 
caffeine release assay (Figure 2). In fact, as previously observed for the release assay 
using dialysis membranes, GfB promoted a slower release of caffeine when compared 
with control, alginate beads or guar-gum films alone. The cross-analysis of dialysis 
release assay and in vitro permeability assay on TR146 buccal mucosa cells indicated a 
strong correlation between caffeine release profile and permeability effectiveness. The 
fact that, when caffeine-loaded alginate beads is combined with guar-gum films, caffeine 
is doubly hindered from being released since both alginate and guar-gum matrices must 
be disintegrated and dissolved before caffeine contacts with buccal cells. Moreover, since 
alginate beads present high mean particle size, permeation of the whole beads is not likely 
to happen unless the integrity of buccal epithelium is somehow compromised. Also, since 
transepithelial permeation study was performed using a static model, swallowing, 
salivation, masticatory movements or even phonation were not considered. Indeed, it is 
predictable that a caffeine solution is almost immediately swallowed after being 
introduced in the oral cavity in in vivo conditions.   
Moreover, after cellular disruption of the TR146 monolayer, it was possible to 
observe (Figure 6) that most caffeine was present either within or retained by the cell 
layer. The fact that guar-gum films, alginate beads and GfB were capable to maintain 
caffeine in intimate contact with the monolayer may enhance permeability of caffeine 
over time, especially in in vivo conditions.  
 
4. Conclusions 
Two new oral/buccal delivery formulations, consisting on a guar gum based film 
and caffeine-loaded alginate beads, were optimized by experimental design. Robustness 
of developed predictive profilers was successfully validated, except for -potential of 
alginate beads (experimental values for -potential of alginate beads were more negative 
than predicted values). Nevertheless, more extreme -potential values are beneficial to 
the stability of alginate beads and less prone to induce toxicity due to disruption of cellular 
membranes. Thus, attempting to achieve a conceptually new delivery system aiming 
buccal and oral delivery of bioactive compounds, alginate beads were dispersed in the 
matrix of guar-gum films. Surface tension analysis allowed to conclude that the 
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synergism between alginate beads and guar-gum films offered a higher water-air stability 
when compared with isolated formulations. Therefore, it is predicted that GfB present 
good capacity to intimately interact with buccal mucosa. ATR-FTIR analysis did not 
indicate the occurrence of new chemical bonds between caffeine and guar-gum films or 
alginate beads. Indeed, subtracted spectra (placebo formulations subtracted from 
caffeinated formulations) for guar-gum films, alginate beads and GfB present the same 
characteristic bands as caffeine anhydrous, demonstrating that chemical structure of 
caffeine was not altered during or after inclusion into guar-gum films, alginate beads or 
in the combination, GfB. Morphological characterization by SEM demonstrated a 
homogeneous dispersion of alginate beads on the guar-gum films matrix, indicating that 
caffeine content is very likely to be homogeneous in each film unit, a good indicator if 
scale-up production is intended. Alginate beads, guar-gum films and GfB did not 
compromise cell viability when tested on TR146 cells, by MTT assay. In vitro release 
profile of caffeine (dialysis membrane) and drug trans-epithelial assay (TR146 buccal 
cells grown on Transwells®) allowed concluding that the combination of guar-gum films 
with alginate beads represent a suitable delivery system when a slower release of carried 
bioactive molecule into oral cavity is intended, when compared with guar-gum films and 
alginate beads alone and with a control (caffeine solution). Also, the highest concentration 
of caffeine was found absorbed/adsorbed to TR146 cell layer when compared with 
alginate beads, guar-gum films or caffeine alone. Results indicate that there is a 
synergistic effect between alginate beads and guar-gum films that promotes an intimate 
contact with buccal epithelia, leading to a more extensive absorption over time, 
corroborating the hypothesis stated by the authors. 
There are not yet similar delivery systems combining beads and films for oral and 
buccal delivery of bioactive molecules reported in the literature even though 
nanoparticles were already incorporated into films for delivery of anti-HIV microbicidal 
drugs in previous works performed by our group [31, 51]. GfB may represent an 
innovative approach on the buccal delivery of hydrophilic bioactive molecules such as 
caffeine to assure controlled effects, being also especially suitable for paediatric or 
psychiatric patients that may be uncooperative to therapy.  
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 Figure 1: Time evolution of water/air superficial tension for the alginate beads containing caffeine along with respective , physical mixture and 
isolated formulation components. 
 
 
Figure 2: Subtracted FTIR spectra corresponding to the caffeine present on alginate beads, GfB, guar-gum 
films caffeine anhydrous powder and the physical mixture of all excipients of GfB. 
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 Figure 3: Caffeine cumulative release (mean ± standard deviation, n=5) across a 500 Da dialysis membrane. 
 
 
 
 
 
Figure 4: Cytotoxicity assessment of different concentrations of caffeinated (alginate beads, guar-gum films and GfB), 
placebo (alginate beads(p), guar-gum films(p) and GfB(p)) formulations.  
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 Figure 5: Cumulative permeability of caffeine (mean ± standard deviation, n=3) across TR146 cells seeded in 
Transwell®. 
 
 
 
Figure 6: Caffeine (mean & ± S.D.) collected from TR146 cell monolayer, by delivery system 
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Table 1: Factorial design parameters established for the optimization of the formulation of guar gum oral films 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Predicted and experimental values obtained for the optimized formulation of guar-gum film 
 Predicted value (mean ± SD) Experimental value (mean ± SD; n= 
6) 
Erosion (%) 39.33 ± 24.61 41.78 ± 3.97 
WU/time(max WU) (mg/s) 4.46 ± 1.48 4.28 ± 0.33 
Distance at burst (mm) 5.77 ± 3.07 5.39 ± 0.65 
Film burst strength (g) 1754.96 ± 2567.36 1595.42 ± 300.13 
 
 
 
Table  3: Factorial design parameters established for the optimization of the formulation of alginate beads 
 
 
 
 
 
 
 
 
 
Factorial design parameters (Guar-gum films) 
 
Level  
(code 
unit) 
Guar gum 
concentration 
 (%, w/v) 
Sorbitol 
concentration  
(%, w/v) 
Citric acid 
concentration  
(%, w/v) 
Caffeine 
concentration 
(mg/mL) 
-1 2.5 3.75 0.75 16.7 
0 3.75 5.69 1.0 16.7 
1 5.0 7.50 1.25 16.7 
 
Factorial design parameters (Alginate beads) 
 
Level 
(code unit) 
Alginate solution 
concentration 
(%, w/v) 
Tween 80 
(%, w/v) 
Caffeine 
concentration 
(mg/mL) 
-1 2 2 16.7 
0 3 3 16.7 
1 4 4 16.7 
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Table 4: Predicted and experimental values obtained for the optimized formulation of alginate beads. 
 Predicted value (mean ± SD) Experimental value (mean ± SD; n= 
6) 
Association efficiency (%) 80.25 ± 4.35 81.57 ± 6.59 
Particle size (m) 3.57 ± 2.25 3.37 ± 0.64 
Polydispersity index 0.300 ± 0.192 0.348 ± 0.060 
-potential (mV) -19.93 ± 7.18 -25.27 ± 1.50 
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